Ashkan Mortezavi

1.5k citations
64 papers · 1.1k indexed · h-index 19

Ashkan Mortezavi

57 papers receiving 1.1k citations

Peers

Ashkan Mortezavi
Comparison fields: 5 of 80
  • Urology 127
  • Pulmonary and Respiratory Medicine 622
  • Rheumatology 171
  • Radiology, Nuclear Medicine and Imaging 157
  • Cancer Research 101
Replace Jeffrey Gahan with:
Jeffrey Gahan United States
Jürgen Breul Germany
Burçin Tuna Türkiye
Qing‐Shui Zheng China
Paulo Antônio Silvestre de Faria Brazil
Xue‐Yi Xue China
Huaiyin Shi China
Giovanna A. Giannico United States
Tatsuaki Yoneda Japan
Wataru Obara Japan
Ashkan Mortezavi relative to Jeffrey Gahan United States Jeffrey Gahan's profile →
Citations per field
00.5×1.6×
Jeffrey Gahan · 1×
Citations per year

Countries citing papers authored by Ashkan Mortezavi

Since Specialization
Citations

This map shows the geographic impact of Ashkan Mortezavi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashkan Mortezavi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashkan Mortezavi more than expected).

Fields of papers citing papers by Ashkan Mortezavi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashkan Mortezavi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashkan Mortezavi. The network helps show where Ashkan Mortezavi may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ashkan Mortezavi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ashkan Mortezavi Line = papers co-authored together Ashkan Mortezavi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20240
3 20236
4 202313
5 20231
6 20227
7 20228
8 202159
9 202014
10 20202
11 202015
12 201815
13 201817
14 201718
15 201718
16 20144
17 20139
18 201184
19 201146
20 200925

About Ashkan Mortezavi

Ashkan Mortezavi is a scholar working on Urology, Pulmonary and Respiratory Medicine and Rheumatology, having authored 64 papers that have together received 1.1k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (36 papers), Prostate Cancer Treatment and Research (32 papers), Urologic and reproductive health conditions (12 papers), Bladder and Urothelial Cancer Treatments (9 papers), Urinary Bladder and Prostate Research (6 papers), Urological Disorders and Treatments (6 papers), Autophagy in Disease and Therapy (5 papers) and Cancer Genomics and Diagnostics (4 papers). The work is most often cited by research in Urology (127 citations), Pulmonary and Respiratory Medicine (622 citations) and Rheumatology (171 citations). Ashkan Mortezavi has collaborated with scholars based in Switzerland, Sweden and Germany. Frequent co-authors include Daniel Eberli, Tullio Sulser, Thomas Hermanns, Holger Moch, Olivio F. Donati, Niels J. Rupp, Peter J. Wild, Benedikt Kranzbühler, Glen Kristiansen and Hans‐Helge Seifert. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Advanced Drug Delivery Reviews.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026